Corneal Thinning During Topical Bevacizumab Therapy
NCT00515684
·
clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Side effect can increase the risk of the research
Conditions
Corneal Neovascularization
Interventions
DRUG:
bevacizumab (Avastin)
Sponsor
Yonsei University